Decreased prothrombotic effects of pegylated recombinant human megakaryocyte growth and development factor in thrombocytopenic state in a rat thrombosis model
- 1 February 2005
- journal article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 3 (2) , 355-360
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- The molecular and cellular biology of thrombopoietin: the primary regulator of platelet productionOncogene, 2002
- Ticlopidine Inhibits the Prothrombotic Effects of Thrombopoietin and Ameliorates Survival after Supralethal Total Body IrradiationThrombosis and Haemostasis, 2002
- Platelets Exposed to Elevated Levels of Endogenous Thrombopoietin In Vivo Have a Reduced Response to Megakaryocyte Growth and Development Factor In VitroThrombosis and Haemostasis, 2001
- Thrombopoietin Activates Human Platelets and Induces Tyrosine Phosphorylation of p80/85 CortactinThrombosis and Haemostasis, 1998
- Effects of Recombinant Human Megakaryocyte Growth and Development Factor (rHuMGDF) on Platelet Production, Platelet Aggregation, and ThrombosisJournal of Thrombosis and Thrombolysis, 1998
- Regulation of platelet activation in vitro by the c-Mpl ligand, thrombopoietinBlood, 1995
- Thrombopoietin: the primary regulator of platelet production [see comments]Blood, 1995
- Purification and Characterization of Thrombopoietin1The Journal of Biochemistry, 1995
- Molecular cloning and characterization of MPL, the human homolog of the v-mpl oncogene: identification of a member of the hematopoietic growth factor receptor superfamily.Proceedings of the National Academy of Sciences, 1992
- Platelet thrombus induced in vivo by filtered light and fluorescent dye in mesenteric microvessels of the ratThrombosis Research, 1984